Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nanog homeobox pseudogene 6 (NANOGP6) is a member of a family of processed pseudogenes derived from the functional homeobox gene NANOG. NANOGP6 is located on human chromosome 10q24.2 and is identified as one of the ten processed pseudogenes (NANOGP2–NANOGP11) related to the canonical NANOG gene, which encodes a homeodomain transcription factor central to embryonic stem cell pluripotency and self-renewal. As a pseudogene, NANOGP6 lacks protein-coding capability and is not considered to have direct molecular function or involvement as a therapeutic target. There are no known biological functions, disease associations, drug interactions, or use as a biomarker specific to NANOGP6[6][1]. Its primary relevance lies in comparative genomics and the evolutionary context of the NANOG gene family.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nanog homeobox pseudogene 6 (NANOGP6).